Development of the COVID-19 Cluster Containment Evaluation System Using the Emergency Management Theory

doi:10.12114/j.issn.1007-9572.2021.00.528

Chinese General Practice ›› 2021, Vol. 24 ›› Issue (17): 2122-2126.DOI: 10.12114/j.issn.1007-9572.2021.00.528

Special Issue: 新型冠状病毒肺炎最新文章合集

• Monographic Research • Previous Articles Next Articles

Development of the COVID-19 Cluster Containment Evaluation System Using the Emergency Management Theory　

1.School of Public Health，Peking University，Beijing 100191，China
2.Vanke School of Public Health，Tsinghua University，Beijing 100084，China
3.School of Population Medicine and Public Health，Peking Union Medical College，Beijing 100730，China
4.Chinese Preventive Medical Association，Beijing 100009，China
5.China Health Education Center，Beijing 100011，China
6.School of Public Health，Capital Medical University，Beijing 100069，China
7.Institute of Basic Medicine，Chinese Academy of Medical Sciences，Peking Union Medical College，Beijing 100730，China
8.Chinese Academy of Inspection and Quarantine，Beijing 100176，China
9.Health Emergency Center，Chinese Center for Disease Control and Prevention，Beijing 102206，China
*Corresponding authors：LIANG Wannian，Professor；E-mail：liangwn@tsinghua.edu.cn
LIU Min，Professor；E-mail：liumin@bjmu.edu.cn

Published:2021-06-15 Online:2021-06-15

基于应急管理理论的新型冠状病毒肺炎聚集性疫情防控效果评价指标体系的构建

1.100191北京市，北京大学公共卫生学院　2.100084北京市，清华大学万科公共卫生与健康学院　3.100730北京市，北京协和医学院群医学及公共卫生学院　4.100009北京市，中华预防医学会　5.100011北京市，中国健康教育中心　6.100069北京市，首都医科大学公共卫生学院　7.100730北京市，中国医学科学院基础医学研究所北京协和医学院基础学院　8.100176北京市，中国检验检疫科学研究院　9.102206北京市，中国疾病预防控制中心卫生应急中心
*通信作者：梁万年，教授；E-mail：liangwn@tsinghua.edu.cn　刘民，教授；E-mail：liumin@bjmu.edu.cn

基金资助:
国家自然科学基金重点项目（71934002）；国家重点研发计划（2020YFC0846300，2020YFC0849500）；国家科技重大专项（2020ZX10001002）

Abstract

Abstract: Background　During the normal prevention and control phase of COVID-19，a number of clusters occurred in China，and all of them have been brought under control．Scientific assessment of the effectiveness of cluster containment helps to timely summarize the experience and shortcomings，contributing to better responding to the epidemic．However，there is still a lack of tools to evaluate the effectiveness of COVID-19 cluster containment．Objective　To develop a COVID-19 cluster containment evaluation system as a tool for assessing the effectiveness of COVID-19 cluster containment．Methods　During November 2020 to February 2021，by use of the emergency management theory，we formulated a theoretical framework，and used it to develop the COVID-19 Cluster Containment Evaluation System involving COVID-19 cluster prevention，responses and containment assessment using literature review and two rounds of Delphi consultation．Results　The system consists of 5 domains（COVID-19 cluster detection and reporting，COVID-19 cluster precise containment，public protection against COVID-19 cluster，medical treatment for COVID-19 cluster，and effectiveness of COVID-19 cluster containment），with 27 items and 107 sub-items．The Kendall's coefficient of concordance ranged from 0.710 to 0.912．The full score for the system is 100 points，and higher score indicates a better effectiveness of containment．Conclusion　This system may be used as an auxiliary tool for assessing the effectiveness of COVID-19 cluster containment in normal prevention and control phase of COVID-19．

Key words: COVID-19, SARS-CoV-2, Epidemic, Evaluation studies as topic, Index system

摘要： 背景　在新型冠状病毒肺炎（COVID-19）疫情常态化防控阶段，我国陆续发生了多起聚集性疫情，均已得到控制。科学评估聚集性疫情防控效果，有助于及时总结经验与不足，更好地应对疫情。然而目前尚缺乏COVID-19聚集性疫情防控效果评价的工具。目的　构建COVID-19聚集性疫情防控效果评价指标体系，为评估聚集性疫情防控效果提供工具。方法　2020年11月—2021年2月，以应急管理理论为基础，构建理论框架。从应急管理的事前预防、事中处置和事后评估的角度，采用文献研究、多轮专家咨询法构建评价指标体系。结果　本研究构建了由5个一级指标（发现报告能力、精准防控能力、公众防护能力、医疗救治效果、疫情防控效果）、27个二级指标和107个三级指标组成的COVID-19聚集性疫情防控效果评价指标体系。专家一致性系数为0.710~0.912，该指标体系用于评价聚集性疫情防控效果满分赋值100分，分数越高防控效果越好。结论　本研究所构建COVID-19聚集性疫情防控效果评价指标体系可为评估疫情常态化防控阶段聚集性疫情防控效果提供参考。

关键词: 新型冠状病毒肺炎, 新型冠状病毒, 疫情, 评价研究（主题）, 指标体系

LIU Jue,LIANG Wannian,LIU Min, et al. Development of the COVID-19 Cluster Containment Evaluation System Using the Emergency Management Theory　[J]. Chinese General Practice, 2021, 24(17): 2122-2126. DOI: 10.12114/j.issn.1007-9572.2021.00.528.
刘珏,梁万年,刘民等. 基于应急管理理论的新型冠状病毒肺炎聚集性疫情防控效果评价指标体系的构建[J]. 中国全科医学, 2021, 24(17): 2122-2126. DOI: 10.12114/j.issn.1007-9572.2021.00.528.

References

［1］梁万年，姚建红，吴敬，等．我国新型冠状病毒肺炎疫情防控常态化阶段的经验与思考［J］．中华医学杂志，2021，101（10）：695-699．
［2］张颖，罗会明，温宁，等．脊髓灰质炎野病毒输入传播风险评估工具的研究［J］．中国疫苗和免疫，2013，19（1）：17-19，80．
ZHANG Y，LUO H M，WEN N，et al．A study of risk assessment tool on wild poliovirus importation and transmission［J］．Chin J Vaccines Immun，2013，19（1）：17-19，80．
［3］ZHONG S，CLARK M，HOU X Y，et al．Progress and challenges of disaster health management in China：a scoping review［J］．Glob Health Action，2014，7：24986．DOI：10.3402/gha.v7.24986．
［4］SUN M，XU N Z，LI C Y，et al．The public health emergency management system in China：trends from 2002 to 2012［J］．BMC Public Health，2018，18（1）：474．DOI：10.1186/s12889-018-5284-1．
［5］刘巧，刘珏，刘民．无症状感染者对COVID-19流行的影响及其防控措施研究［J］．中国全科医学，2021，24（8）：917-922．
LIU Q，LIU J，LIU M．Role and containment of asymptomatic cases in COVID-19 transmission［J］．Chin Gen Pract，2021，24（8）：917-922．
［6］RA S H，LIM J S，KIM G U，et al．Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection［J］．Thorax，2021，76（1）：61-63．DOI：10.1136/thoraxjnl-2020-215042．
［7］HE X，LAU E H Y，WU P，et al．Temporal dynamics in viral shedding and transmissibility of COVID-19［J］．Nat Med，2020，26（5）：672-675．DOI：10.1038/s41591-020-0869-5．
［8］World Health Organization．Coronavirus disease（COVID-19）：How is it transmitted?［EB/OL］．（2020-07-09）［2021-03-04］．https：//www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted．
［9］CHU D K，AKL E A，DUDA S，et al．Physical distancing，face masks，and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19：a systematic review and meta-analysis［J］．Lancet，2020，395（10242）：1973-1987．DOI：10.1016/S0140-6736（20）31142-9．
［10］ZHU F C，LI Y H，GUAN X H，et al．Safety，tolerability，and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine：a dose-escalation，open-label，non-randomised，first-in-human trial［J］．Lancet，2020，395（10240）：1845-1854．DOI：10.1016/S0140-6736（20）31208-3．
［11］中华人民共和国国务院新闻办公室．抗击新冠肺炎疫情的中国行动［EB/OL］．（2020-06-07）［2021-03-04］．http：//www.scio.gov.cn/ztk/dtzt/42313/43142/index.htm．
［12］万时雨，刘珏，刘民．新型冠状病毒基本再生数研究进展［J］．科学通报，2020，65（22）：2334-2341．
WAN S Y，LIU J，LIU M．Progress on the basic reproduction number of SARS-CoV-2［J］．Chin Sci Bull，2020，65（22）：2334-2341．
［13］国家卫生健康委员会．新型冠状病毒肺炎诊疗方案（试行第八版）［EB/OL］．（2020-08-19）［2021-03-04］．http：//www.nhc.gov.cn/yzygj/s7653p/202008/0a7bdf12bd4b46e5bd28ca7f9a7f5e5a.shtml．
［14］WU Y，JING W Z，LIU J，et al．Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries［J］．Sci Total Environ，2020，729：139051．DOI：10.1016/j.scitotenv.2020.139051．
［15］YUAN J，WU Y，JING W Z，et al．Non-linear correlation between daily new cases of COVID-19 and meteorological factors in 127 countries［J］．Environ Res，2021，193：110521．DOI：10.1016/j.envres.2020.110521．

[1]	SHI Xiaoxiao, SHI Jianwei, JIN Hua, ZHANG Qianqian, YU Dehua. Development of the Coordinated Regional Health Development Assessment System [J]. Chinese General Practice, 2023, 26(25): 3153-3156.
[2]	XU Yifan, JING Limei, WANG Lili, WANG Zhaolin, LI Yuhan, LU Wenyuan, ZHANG Qinhua, WANG Haoran, JING Jiaheng, LI Shuijing. Development of a Comprehensive Assessment System of Hospice Care [J]. Chinese General Practice, 2023, 26(22): 2793-2799.
[3]	ZUO Xu, HUANG Zhaolan, LU Biao. Differences between the First and Another 3-day Blood Pressure Levels and Associated Factors in a Self-reported Non-hypertensive Population Aged 35-64 Years [J]. Chinese General Practice, 2023, 26(22): 2771-2777.
[4]	WU Jian, YU Chengcheng, YANG Yinmei, XIA Qingyun, LI Quanman, FU Xiaoli. COVID-19 Vaccination Behavior and Its Influencing Factors among the Elderly in Four Regions of China [J]. Chinese General Practice, 2023, 26(22): 2763-2770.
[5]	HE Mei, LI Hui, MU Lifeng, YANG Ming. Effect of Azovudine on Hepatic and Renal Function in Patients with COVID-19: a Case Series Study [J]. Chinese General Practice, 2023, 26(20): 2476-2481.
[6]	WANG Hai, WANG Zhuoli, PEI Honghong, PAN Longfei. Analysis of Risk Factors and Exploration of Predictors of Serious Cases of COVID-19 in Xi'an during the Period of 2021-2022 [J]. Chinese General Practice, 2023, 26(17): 2132-2137.
[7]	YAN Yuge, HUANG Jiaoling. Visualization Analysis of Primary Healthcare Research during the COVID-19 Pandemic [J]. Chinese General Practice, 2023, 26(16): 2027-2035.
[8]	National Center of Gerontology, Electrocardiology and Cardiac Function Branch of Chinese Geriatric Society, Imaging Group of Cardiovascular Department, Beijing Medical Association, Chinese Medical and Health Culture Association Cardiovascular Health and Science Sports Branch of China Health Culture Association. Expert Consensus for Management of Myocardial Injury, Myocarditis, and Post-infection Condition with Coronavirus Disease 2019 (Second Edition) [J]. Chinese General Practice, 2023, 26(14): 1692-1702.
[9]	HUA Qiaoli, LIU Huiling, XU Xiaohua, ZHENG Danwen, WANG Qian, LIU Yuntao, ZHOU Xin, YANG Rongyuan, DING Banghan, GUO Jianwen, ZHANG Zhongde. Prevalence and Associated Factors of Very Early Cognitive Impairment in COVID-19 Convalescents: a Study Using Data from a Questionnaire Survey [J]. Chinese General Practice, 2023, 26(10): 1234-1240.
[10]	YANG Hui. Prevention and Control of the COVID-19 Epidemic and Management of Chronic Disease [J]. Chinese General Practice, 2023, 26(07): 780-782.
[11]	SHI Weijuan, WANG Fengyan, YANG Yuqiong, XIE Qingxiu, LI Yuqi, LI Shiyue, CHEN Rongchang, ZHANG Dongying, ZHENG Jinping, LIANG Zhenyu. Impact of COVID-19 Pandemic on the Frequency of Acute Exacerbations of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2023, 26(05): 550-556.
[12]	ZHANG Weizong, YUAN Hong, SUN Jindong, YU Huamin, SHI Mingjuan, HU Haiqiang, HE Haiying, YE Li, ZHANG Huihui, BAI Xinghua, SHEN Chaofeng, TU Sijia, WANG Yang, WANG Gang, ZHAO Xiaofeng, YU Tao, LI Cairong, ZHANG Zhi, ZHOU Donglai, CAI Mengyang, NING Le. Risk Factors of In-hospital Death in COVID-19 Patients: a Meta-analysis [J]. Chinese General Practice, 2023, 26(05): 607-620.
[13]	HUANGFU Xiaojuan, LI Xiaojuan, CHEN Min, LIU Jihong, ZHAI Rui, CAI Zhipeng, LI Litao. A Meta-analysis of the Impact of COVID-19 on Stroke Mortality [J]. Chinese General Practice, 2023, 26(03): 348-355.
[14]	HAN Siyu, LI Duoduo, CAI Meiling, YU Changhe. Comparative Study of the Royal TCM-based Tendon-regulation Manipulation and Joint Mobilization for Knee Osteoarthritis [J]. Chinese General Practice, 2023, 26(02): 210-219.
[15]	CHANG Chun, SUN Yongchang. Global Strategy for Asthma Management and Prevention: Interpretation of the Updates in 2022 [J]. Chinese General Practice, 2022, 25(35): 4355-4362.

Development of the COVID-19 Cluster Containment Evaluation System Using the Emergency Management Theory

基于应急管理理论的新型冠状病毒肺炎聚集性疫情防控效果评价指标体系的构建

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments